Global Cancer Immunotherapy Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cancer Immunotherapy Market Overview

• 1.1 Product Overview and Scope of Cancer Immunotherapy
• 1.2 Classification of Cancer Immunotherapy by Types
  • 1.2.1 Global Cancer Immunotherapy Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cancer Immunotherapy Revenue Market Share by Types in 2018
  • 1.2.3 Monoclonal Antibodies
  • 1.2.4 Immune Checkpoint Inhibitors
  • 1.2.5 Immune System Modulators
  • 1.2.6 Cancer Vaccines
• 1.3 Global Cancer Immunotherapy Market by Application
  • 1.3.1 Global Cancer Immunotherapy Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Lung Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 Colorectal Cancer
  • 1.3.5 Melanoma
  • 1.3.6 Prostate Cancer
  • 1.3.7 Others
• 1.4 Global Cancer Immunotherapy Market by Regions
  • 1.4.1 Global Cancer Immunotherapy Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cancer Immunotherapy Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cancer Immunotherapy Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cancer Immunotherapy Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cancer Immunotherapy Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cancer Immunotherapy Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cancer Immunotherapy (2014-2024)

2 Manufacturers Profiles

• 2.1 Amgen
  • 2.1.1 Business Overview
  • 2.1.2 Cancer Immunotherapy Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Amgen Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 AstraZeneca
  • 2.2.1 Business Overview
  • 2.2.2 Cancer Immunotherapy Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 AstraZeneca Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Roche
  • 2.3.1 Business Overview
  • 2.3.2 Cancer Immunotherapy Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Roche Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bayer
  • 2.4.1 Business Overview
  • 2.4.2 Cancer Immunotherapy Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bayer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Bristol-Myers Squibb
  • 2.5.1 Business Overview
  • 2.5.2 Cancer Immunotherapy Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Bristol-Myers Squibb Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 Eli Lilly
  • 2.6.1 Business Overview
  • 2.6.2 Cancer Immunotherapy Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Eli Lilly Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Merck
  • 2.7.1 Business Overview
  • 2.7.2 Cancer Immunotherapy Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Merck Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Novartis
  • 2.8.1 Business Overview
  • 2.8.2 Cancer Immunotherapy Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Novartis Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 Pfizer
  • 2.9.1 Business Overview
  • 2.9.2 Cancer Immunotherapy Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Pfizer Cancer Immunotherapy Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cancer Immunotherapy Market Competition, by Players

• 3.1 Global Cancer Immunotherapy Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cancer Immunotherapy Players Market Share
  • 3.2.2 Top 10 Cancer Immunotherapy Players Market Share
• 3.3 Market Competition Trend

4 Global Cancer Immunotherapy Market Size by Regions

• 4.1 Global Cancer Immunotherapy Revenue and Market Share by Regions
• 4.2 North America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.5 South America Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

5 North America Cancer Immunotherapy Revenue by Countries

• 5.1 North America Cancer Immunotherapy Revenue by Countries (2014-2019)
• 5.2 USA Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

6 Europe Cancer Immunotherapy Revenue by Countries

• 6.1 Europe Cancer Immunotherapy Revenue by Countries (2014-2019)
• 6.2 Germany Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.3 UK Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.4 France Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cancer Immunotherapy Revenue by Countries

• 7.1 Asia-Pacific Cancer Immunotherapy Revenue by Countries (2014-2019)
• 7.2 China Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.5 India Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

8 South America Cancer Immunotherapy Revenue by Countries

• 8.1 South America Cancer Immunotherapy Revenue by Countries (2014-2019)
• 8.2 Brazil Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cancer Immunotherapy by Countries

• 9.1 Middle East and Africa Cancer Immunotherapy Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cancer Immunotherapy Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cancer Immunotherapy Revenue and Growth Rate (2014-2019)

10 Global Cancer Immunotherapy Market Segment by Type

• 10.1 Global Cancer Immunotherapy Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cancer Immunotherapy Market Forecast by Type (2019-2024)
• 10.3 Monoclonal Antibodies Revenue Growth Rate (2014-2024)
• 10.4 Immune Checkpoint Inhibitors Revenue Growth Rate (2014-2024)
• 10.5 Immune System Modulators Revenue Growth Rate (2014-2024)
• 10.6 Cancer Vaccines Revenue Growth Rate (2014-2024)

11 Global Cancer Immunotherapy Market Segment by Application

• 11.1 Global Cancer Immunotherapy Revenue Market Share by Application (2014-2019)
• 11.2 Cancer Immunotherapy Market Forecast by Application (2019-2024)
• 11.3 Lung Cancer Revenue Growth (2014-2019)
• 11.4 Breast Cancer Revenue Growth (2014-2019)
• 11.5 Colorectal Cancer Revenue Growth (2014-2019)
• 11.6 Melanoma Revenue Growth (2014-2019)
• 11.7 Prostate Cancer Revenue Growth (2014-2019)
• 11.8 Others Revenue Growth (2014-2019)

12 Global Cancer Immunotherapy Market Size Forecast (2019-2024)

• 12.1 Global Cancer Immunotherapy Market Size Forecast (2019-2024)
• 12.2 Global Cancer Immunotherapy Market Forecast by Regions (2019-2024)
• 12.3 North America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
• 12.4 Europe Cancer Immunotherapy Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cancer Immunotherapy Revenue Market Forecast (2019-2024)
• 12.6 South America Cancer Immunotherapy Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cancer Immunotherapy Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology